These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12921927)

  • 1. Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
    Donovan JL; Peters TJ; Noble S; Powell P; Gillatt D; Oliver SE; Lane JA; Neal DE; Hamdy FC;
    J Clin Epidemiol; 2003 Jul; 56(7):605-9. PubMed ID: 12921927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring factors influencing recruitment results of nurses recruiting diabetes patients for a randomized controlled trial.
    Vluggen S; Hoving C; Vonken L; Schaper NC; de Vries H
    Clin Trials; 2020 Aug; 17(4):448-458. PubMed ID: 32367737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient advocacy and patient centredness in participant recruitment to randomized-controlled trials: implications for informed consent.
    Tomlin Z; deSalis I; Toerien M; Donovan JL
    Health Expect; 2014 Oct; 17(5):670-82. PubMed ID: 22712887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training health professionals to recruit into challenging randomized controlled trials improved confidence: the development of the QuinteT randomized controlled trial recruitment training intervention.
    Mills N; Gaunt D; Blazeby JM; Elliott D; Husbands S; Holding P; Rooshenas L; Jepson M; Young B; Bower P; Tudur Smith C; Gamble C; Donovan JL
    J Clin Epidemiol; 2018 Mar; 95():34-44. PubMed ID: 29191445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of health research study participant recruitment strategies: a systematic review.
    Huynh L; Johns B; Liu SH; Vedula SS; Li T; Puhan MA
    Clin Trials; 2014 Oct; 11(5):576-83. PubMed ID: 24980278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.
    Donovan J; Mills N; Smith M; Brindle L; Jacoby A; Peters T; Frankel S; Neal D; Hamdy F
    BMJ; 2002 Oct; 325(7367):766-70. PubMed ID: 12364308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost talk: protocol for a stepped-wedge cluster randomized trial of an intervention helping patients and urologic surgeons discuss costs of care for slow-growing prostate cancer during shared decision-making.
    Politi MC; Forcino RC; Parrish K; Durand MA; O'Malley AJ; Elwyn G
    Trials; 2021 Jun; 22(1):422. PubMed ID: 34187547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences.
    Mills N; Blazeby JM; Hamdy FC; Neal DE; Campbell B; Wilson C; Paramasivan S; Donovan JL
    Trials; 2014 Aug; 15():323. PubMed ID: 25115160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the clinical outcome and cost-effectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET).
    Williams J; Russell I; Durai D; Cheung WY; Farrin A; Bloor K; Coulton S; Richardson G
    Health Technol Assess; 2006 Oct; 10(40):iii-iv, ix-x, 1-195. PubMed ID: 17018229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of recruiting couples to a clinical trial.
    Sadler GR; Ko CM; Malcarne VL; Banthia R; Gutierrez I; Varni JW
    Contemp Clin Trials; 2007 Jul; 28(4):423-32. PubMed ID: 17218166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.
    Elliott D; Hamdy FC; Leslie TA; Rosario D; Dudderidge T; Hindley R; Emberton M; Brewster S; Sooriakumaran P; Catto JWF; Emara A; Ahmed H; Whybrow P; le Conte S; Donovan JL
    BJU Int; 2018 Dec; 122(6):970-977. PubMed ID: 29888845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
    Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
    Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - Quanti-Qualitative Appointment Timing.
    Paramasivan S; Strong S; Wilson C; Campbell B; Blazeby JM; Donovan JL
    Trials; 2015 Mar; 16():88. PubMed ID: 25873096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
    Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
    Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
    Donovan JL; Opmeer B; Young GJ; Mills N; Martin RM; Lane JA; Metcalfe C; Peters TJ; Davis M; Turner EL; Walsh E; Neal DE; Hamdy FC;
    J Clin Epidemiol; 2019 Sep; 113():200-213. PubMed ID: 31170515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study for a randomized controlled trial comparing the efficacy, safety and cost-effectiveness of surgical treatments of the prostate.
    Bryan NP; Byrne L; Hastie KJ; Anderson JB; Moore KT; Chapple CR
    BJU Int; 1999 Feb; 83(3):249-53. PubMed ID: 10233488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
    Lewis AL; Young GJ; Selman LE; Rice C; Clement C; Ochieng CA; Abrams P; Blair PS; Chapple C; Glazener CM; Horwood J; McGrath JS; Noble S; Taylor GT; Lane JA; Drake MJ
    Health Technol Assess; 2020 Sep; 24(42):1-122. PubMed ID: 32902375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
    Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R
    Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.